Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LPV/r (Kaletra) + tenofovir vs standard of care in treatment-naive HIV-1 infection
2004-000786-35Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in human immunodeficiency virus infection (HIV) comparing Kaletra + tenofovir disoproxil with Standard of care: Kaletra + 2 nucleoside RTIs (2 arms). Started Apr 2005; status: completed.
02
Drugs
lopinavir + ritonavirtenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2004-000786-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000786-35.